Applied Dna Sciences earnings were -$23.6M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest APDN earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$17.5M, up 432.2% from last quarter. For the last reported fiscal year 2024 ending Sep 30, 2024, APDN reported annual earnings of -$7.2M, with -27.4% growth. The next APDN earnings date is May 8, 2025.
Applied Dna Sciences Earnings Reports & History FAQ
What were Applied Dna Sciences's earnings last quarter?
On APDN's earnings call on Invalid Date, Applied Dna Sciences (NASDAQ: APDN) reported Q4 2024 earnings per share (EPS) of -$28.00, up 67.63% year over year. Total APDN earnings for the quarter were -$17.55 million. In the same quarter last year, Applied Dna Sciences's earnings per share (EPS) was -$86.50.
The next APDN earnings date is Invalid Date. Add APDN to your watchlist to be reminded of Applied Dna Sciences's next earnings date.
What was APDN's earnings growth in the past year?
As of Applied Dna Sciences's earnings date in Invalid Date, Applied Dna Sciences's earnings has grown year over year. APDN earnings in the past year totalled -$23.59 million.
Is Applied Dna Sciences profitable or losing money?
As of the last Applied Dna Sciences earnings report, Applied Dna Sciences is currently losing money. Applied Dna Sciences's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$8.53 million, a 18.28% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.